Michael Rexhouse is a Senior Engineer in Plant Engineering at Genentech’s Hillsboro Individualized Therapies (HIT) Facility, where they have been since 2022. Previously, they held various engineering roles, including Process Engineer at DPS Group Global and Consultant positions at Eli Lilly and Company and Genzyme from 2014 to 2016. Michael also served as a Senior Engineer/Engineering Project Manager at Genentech from 2019 to 2021. They are currently pursuing education at the State University of New York College at Geneseo, the University at Albany, SUNY, and the National University of Ireland, Galway.
This person is not in the org chart
This person is not in any teams
This person is not in any offices